PaxMedica, Inc.
PXMD
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.78M | 10.43M | 11.71M | 12.23M | 13.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.96M | 15.44M | 15.80M | 16.15M | 16.74M |
| Operating Income | -11.96M | -15.44M | -15.80M | -16.15M | -16.74M |
| Income Before Tax | -13.49M | -17.66M | -18.15M | -18.29M | -17.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.49 | -17.66 | -18.15 | -18.29 | -17.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.49M | -17.66M | -18.15M | -18.29M | -17.59M |
| EBIT | -11.96M | -15.44M | -15.80M | -16.15M | -16.74M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2.44 | -7.54 | -11.20 | -15.86 | -21.84 |
| Normalized Basic EPS | -1.58 | -4.54 | -6.82 | -9.70 | -13.25 |
| EPS Diluted | -2.44 | -7.54 | -11.20 | -15.86 | -21.84 |
| Normalized Diluted EPS | -1.58 | -4.54 | -6.82 | -9.70 | -13.25 |
| Average Basic Shares Outstanding | 28.20M | 20.12M | 13.32M | 6.65M | 3.28M |
| Average Diluted Shares Outstanding | 28.20M | 20.12M | 13.32M | 6.65M | 3.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |